Cases with Hyperplasia and Neoplasia in Endocrine Glands in Dogs by GAL, Adrian Florin et al.
INTRODUCTION
Endocrine tumors are found sporadically 
in both humans and animals. They have the ori-
gin in endocrine organs or in the diffuse neuro-
endocrine system (APUD - Amine Precursor 
Uptake Decarboxylase). Endocrine tumors can be 
classiϐied according to their behavior and induced 
dysfunctions in: hyperplastic lesions, benign or 
malignant tumors. Endocrine glands hyperplasia 
determines an aberrant secretion of hormones 
and is grossly associated with increased volume of 
the endocrine gland affected. Endocrine adenomas 
and carcinomas are often similar histologically, 
which makes histological diagnosis to be a challen-
ge (Baba and Catoi, 2007). 
The hypertrophy of the endocrine gland, as a 
consequence of tumor extension, often leads to the 
compression atrophy of nearby organs. Malignant 
tumors cause destruction of both the affected 
gland and its adjacent tissue, as a consequence of 
the invasion (Withrow et al., 2012). 
Primary endocrine neoplasms may occur as 
single or multiple entities. The latter can cause a 
syndrome called Multiple Endocrine Neoplasia 
(MEN) syndrome if tumors occur in the following 
organs: pancreas, thyroid, parathyroid, adrenal 
and pituitary glands. MEN has been described in 
a very small number of species and cases: in horse 
(De Cock, 1999), dog (Brever et al., 1991; Walker 
et al., 2000), cat and ox (Sponenberg, 1983). They 
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Abstract
Endocrine tumors are found sporadically in both humans and animals. They originate from endocrine organs 
and diffuse neuroendocrine system. The present paper describes cases of tumors/hyperplasia in various endocrine 
glands in dogs. The material included canine corpses and biopsies brought for necropsy and/or h istological 
examination, which occurred in the Department of Pathological Anatomy (Faculty of Veterinary Medicine, Cluj-
Napoca, Romania). Tissue samples were collected, ϐixed in 10% buffered formalin and routinely processed for 
histology. In all cases the canine endocrine tumors were diagnosed only after necropsy. In some cases simple 
endocrine neoplasms were identiϐied, while in other cases multiple endocrine tumors were observed. Testicular 
Sertoli cell tumors and/or Leydig cell tumor can be considered endocrine tumors since (in some cases) the clinical 
manifestations are relatively sharp. In one case bearing Sertoli cell tumor we observed the feminization syndrome. 
Concerning adrenal glands, cortical adenoma, carcinoma and medullar pheocromocytoma were diagnosed in three 
dogs respectively. Thyroidal tumors were either with the proliferation of follicular cells or with the involvement 
of parafollicular cells. In one dog showing a thyroidal tumor and bilateral hyperplasia of the parathyroid glands, 
multiple endocrine lesions were also observed, in a picture of Multiple Endocrine Neoplasia (MEN) syndrome. 
Similar condition was demonstrated in two other dogs with concomitant testicular and adrenal tumors. This is 
the ϐirst description of this syndrome in dogs in Romania. Endocrine tumors are extremely rare in animals. In dogs 
suspected to bear endocrine tumors, it is essential to investigate all endocrine glands to determine if the subject 
presents MEN or MEN-like syndrome.
Keywords: dog, endocrine tumor, MEN-syndrome.
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are characterized by the presence of at least two 
endocrine tumors (including hyperplastic lesions) 
in the same subject. Genetic substrate (i.e., 
autosomal dominant gene) has been suggested by 
some authors (Phay et al., 2000; Thakker, 2000).
Our paper presents cases with tumors/hyper-
plastic lesions in various endocrine glands in dogs 
that have been diagnosed in the Department of 
Pathology (Faculty of Veterinary Medicine Cluj-
Napoca, Romania). For each case, a description 
concerning the case history, necropsy and 
histological ϐindings encountered is given.
MATERIALS AND METHODS
The material included dog corpses and 
biopsies submitted to necropsy and/or histolo-
gical examination in the Department of Patho-
logical Anatomy (Faculty of Veterinary Medicine, 
Cluj-Napoca, Romania). The following data were 
recorded for each case: age, breed, dog history, 
necropsy ϐindings (for some cases), tumor(s) 
site including gross ϐindings (i.e., the tumor size, 
consistency, appearance of the tumor in cross 
section). Neoplastic samples were collected, 
ϐixed in 10% buffered formalin and routinely 
processed for histology. From parafϐin blocks, 
5 micron thick sections were obtained and 
stained with Hematoxylin-eosin (HE). Histologic 
examination was performed using the Olympus 
BX51 microscope connected to a digital camera 
(Olympus DP-25). 
RESULTS AND DISCUSSION
The results assessed in the cases examined 
are shown in Table 1. 
Research conducted in the Department of 
Pathology and Necropsy (FVM Cluj-Napoca) shows 
that endocrine tumors in dogs are rare entities and 
often diagnosed only after necropsy. Investigated 
cases showed simple and multiple endocrine 
lesions (i.e., tumors and/or hyperplasia) in the 
following organs: testis, thyroid, parathyroid, and 
adrenal glands.
Testicular tumors (e.g., Sertoli cells tumor, 
Leydig cells tumor) were the most common 
endocrine tumors diagnosed (four cases; Figs. 
1-3). Frequently, the clinical manifestations 
associated with these tumors are relatively clear 
and can raise the suspicion of tumor at this level. 
Sertoli cell tumors are endocrine tumors since 
the estrogen hypersecretion regularly occurs. As 
noted in the cases 1, 3, and 4, they were associated 
with the feminization syndrome suggested by 
the prepuce swelling, reduced hairiness, skin 
hyperpigmentation, skin thinning, etc. These 
clinical signs can be helpful for a veterinary 
clinician in the diagnosis of Sertoli cell tumor. 
Furthermore, such tumors can be associated with 
a myelodysplastic syndrome that predispose to 
infection. The paraneoplastic syndrome, manifested 
by the feminization in males, was suggested by 
other reports (Brodey et al., 1958; Lipowitz et al., 
1973; Reif et al., 1979; Weaver, 1983).
Sertoli cells tumor is the most common neo-
plasm of the testis (about 90% of all gynecological 
malignancies in male; Cotchin, 1960; von 
Bomhard et al., 1978, Liao et al., 2009). Risk 
factors incriminated for dogs: cryptorchidism, 
age, breed and various carcinogens (Hayes, 1990; 
Hayes et al., 1995). There seems to be a link 
between cryptorchidism and the emergence of 
Sertoli cells tumor and seminoma. Apparently, 
the cryptorchidism doesn’t interfere with the 
occurrence of interstitial Leydig cell tumors (Reif 
et al., 1969; Reif et al., 1979; Liao et al., 2009). 
Another endocrine lesion that may occur in 
testis is the hyperplasia/neoplasia of Leydig cells. 
They may be associated with the hypersecretion 
of testosterone. The hyperplasia of the Leydig 
gland may progress as a solitary neoplastic or 
hyperplastic lesion (case 2) or may be associated 
with other testicular tumors (case 4, Fig. 3).
Some other two dogs had hyperplastic lesions 
(Cases 5 and 6; Figs. 4, 6, 7) in the adrenal gland. 
In one dog was diagnosed an adrenocortical 
adenoma (Case 6; Fig. 6, 7), whereas the other 
one presented an adrenocortical malignant tumor 
(Case 5; Fig. 4). Depending on the affected portion, 
the adrenal gland tumors may be associated with 
different clinical manifestations. However, in the 
cases studied, such manifestations were absent 
and the diagnosis was established after necropsy 
(incidental ϐinding of adrenal gland lesions in both 
dogs). Adrenal adenomas are four times more 
common than carcinomas and are usually smaller 
than two cm comparing to carcinomas (Labelle 
et al., 2004; Feldman et al., 2004). About 50% 
of all adrenocortical carcinomas metastasize in 
various organs (e.g., the lung, kidney, ovary, etc.; 
Labelle, 2004). Functional adrenocortical tumors 
are very common. They are able to elaborate 
several hormones, such as: androsterone, proges-
GAL et al
339
Bulletin UASVM Veterinary Medicine 71 (2) / 2014
Cases with Hyperplasia and Neoplasia in Endocrine Glands in Dogs














-left testis -7,5/6 cm
-Intratubular testicular 
Sertoli cell tumor
-skin tumor -2/2,5 cm -Eccrine gland adenoma
2. Male 10 Rottweiler No -left testis -6,5/6 cm -Angiomatoid Leydig cell tumor
3. Male 10 Canish No
-right testis (retained 




Sertoli cell tumor 
4. Male 9 Canish No
-right testis (bilateral 
cryptorchidism)
-6 cm -In the both testes: 
Intralobular Sertoli cell 
tumor, diffuse seminoma 
(multifocal), and interstitial 
Leydig gland hyperplasia
-left testis (bilateral 
cryptorchidism)
-5,5 cm








(proliferation of the both 






Yes -thyroid gland -8/5 cm -Medullary thyroid carcinoma 
8. Male 10 Canish No 
-right thyroid gland -3,5/3 cm
-Follicular adenoma of 
the thyroid gland
-right parathyroid glands -0,5 cm
-Parathyroid gland hyperplasia 





-Compact follicular carcinoma 
of the thyroid gland
-left parathyroid glands 0,5 cm
-Parathyroid gland hyperplasia 
(with metastatic mineralization 
in other tissues)
Fig 1. Angiomatoid Leydig cell tumor (case 2) - large 
vascular spaces; HE stain.
Fig 2. Invasive Sertoli cell tumor (case 3) – foamy 
aspect of the tumoral cells; HE stain.
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Fig. 3. Sertoli cell tumor (right testis) - interstitial 
Leydig cell hyperplasia (case 4); HE stain.
Fig. 4. Adrenocortical carcinoma (case 5) 
- neoplastic cells set in short cords/nests; 
macronuclei; HE stain.
Fig. 5. Pheochromocytoma (adrenal medulla; 
case 6) – tumoral cell mass – accolade; HE stain.
Fig. 6. Adrenocortical adenoma (case 6) 
– extension of zona gromerulosa in zona 
fasciculata; HE stain.
Fig. 7. Adrenocortical adenoma (case 6) – 
nodular hyperplasia of sponge cells from zona 
fasciculata; HE stain.
Fig. 8. Thyroidal carcinoma (left thyroid) – 
haemorrhagic and necrotic microfoci in the 
tumoral mass (case 8); HE stain.
GAL et al
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terone, testosterone, estradiol and in rare cases 
cortisol or aldosterone (Conn’s syndrome). In 
cats, aldosterone-secreting tumors are the most 
common adrenal tumors. They occur in elderly 
individuals with clinical signs of muscle weakness, 
hypokalemia and hypertension (Djajadiningrat-
Laanen, 2011; Rossmeils et al., 2000).
In addition, tumors may occur in the adrenal 
medulla (i.e., the pheochromocytoma). They are 
generally malignant with metastasis rate of 40% 
in the lungs, liver, spleen, bone, central nervous 
system (Gillson, 1994). Around 82% of them 
generate vascular invasion (Killes et al., 2003). In 
our case (Case 6), the clinical history didn’t suggest 
a possible tumor in the adrenal medulla. The 
tumor was detected incidentally after necropsy. 
The main clinical symptoms that may occur in 
dogs with pheochromocytomas (often malignant) 
are: muscle weakness, recurrent collapse, anxiety, 
exercise intolerance, decreased appetite, weight 
loss, polyuria, polydipsia, cardiac arrhythmias, 
tachycardia, and hypertension (Herrera et al., 
2010).
Endocrine thyroidal tumors were diagnosed 
in the cases 7 and 8 (Fig. 8). In one case a 
thyroidal tumor with follicular cells (Case 8; 
Fig. 8) was diagnosed, whereas the other dog 
showed thyroidal tumor with parafollicular cells 
(case 7). The clinical history didn’t suggest their 
existence. Concerning the clinical signs, they 
may include the following: tachycardia, dyspnea, 
dysphagia, dysphonia, laryngeal paralysis, Horner 
syndrome and facial edema. In some dogs with 
hyperthyroidism the following symptoms may also 
occur: polyphagia, weakening, muscle weakness, 
polyuria and polydipsia (Feldman et al., 2004; 
Bezzola et al., 2002).
Parathyroid glands tumors are very rare. In 
the presented study, we diagnosed a bilateral 
hyperplasia of parathyroid glands (case 8). The 
latter aspect was rarely described in human 
endocrine pathology and even less in animal 
pathology. The hyperplasia or benign tumors of the 
parathyroid glands may provoke paraneoplastic 
syndromes that may be useful to establish the 
diagnosis (e.g., hypercalcemia, polyuria, polydipsia, 
lethargy, loss of appetite, weight loss, vomiting, 
urinary tract infection; Argyle et al., 2008).
A particular condition occurred in one dog 
showing multiple endocrine tumors (Case 8). 
This condition, defined Multiple Endocrine 
Neoplasia (MEN) syndrome was described 
in few species, such as: horse, dog, cat and 
ox (Sponenberg et al., 1983; De Cock, 1999; 
Berger et al., 1991; Walker et al., 2000). MEN 
is characterized by the presence of at least 
one endocrine tumor associated with another 
(or others) hyperplastic or tumoral endocrine 
lesion. The genetic substrate for this syndrome 
was suggested in humans and animals (i.e., 
autosomal dominant gene; Phay et al., 2000; 
Thakker, 2000). This is the first description 
of MEN in dogs in Romania. The investigated 
dog presented thyroidal carcinoma (right 
thyroid), thyroidal adenoma (left thyroid), and 
hyperplasia of both parathyroid glands (i.e., 
bilateral). Phay et al. (2000) describe several 
types of MEN in dogs (i.e., MEN-1, MEN-2, MEN-
2b). In the present report we observed a mixed 
MEN (or, according to some authors, the MEN-
2b type).
However, MEN-like lesions were diagnosed 
in other two cases. A dog (Case 4) showed 
multiple endocrine lesions in testes, namely a 
testicular Sertoli cells tumor associated with 
hyperplasia of the interstitial Leydig gland. 
Another dog (Case 6) was diagnosed with 
multiple endocrine lesions in the adrenal gland. 
Accordingly, a benign pheochromocytoma and 
hyperplastic lesions in the adrenal cortex (i.e., 
hyperplasia of the cortisol-dependent and 
aldosterone-dependent areas) were diagnosed 
in the Case no. 6. The presented cases could 
correspond to a MEN syndrome since some 
testicular tumors (Sertoli and Leydig cell 
tumors) are able to elaborate hormones (as 
shown above) (Morgan et al., 1982). The rarity 
of MEN-like syndromes makes this situation to 
be less investigated. The genetic involvement of 
MEN-like lesions remains to be demonstrated.
CONCLUSION
Endocrine tumors are extremely rare enti-
ties in animals. In most circumstances the clini-
cal diagnosis is not easy; sometimes even the 
histological assessment is difϐicult to make a 
distinction between hyperplastic and neoplastic 
lesions. In subjects with endocrine disturbances, 
it is essential to investigate all endocrine glands 
in order to determine if the subject has or not the 
MEN or MEN-like syndromes.
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